BDP9066 (Standard)

BDP9066 (Standard) is the analytical standard of BDP9066 (HY-111424). This product is intended for research and analytical applications. BDP9066 is a potent and selective myotonic dystrophy-related Cdc42-binding Kinase MRCK inhibitor with an IC50 of 64 nM for MRCKβ in SCC12 cells, Ki values of 0.0136 nM and 0.0233 nM for MRCKα/β in house determinations, respectively. BDP9066 has therapeutic effect on sKin cancer by reducing substrate phosphorylation.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • CAS. Nr.: 2226507-04-4
  • Formel: C20H24N6
  • Molecular Weight:348.44
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Product Information
  • Chemical Information
  • Reinheit & Dokumentation
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00